Details der Publikation - Fluorescence Endoscopy of Esophageal Carcinoma

See brief summary.

Medienart:	Klinische Studie

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	ClinicalTrials.gov - (2024) vom: 16. Apr. Zur Gesamtaufnahme - year:2024

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Esophageal Neoplasms Phase: Phase 1 Recruitment Status: Terminated Study Type: Interventional

Anmerkungen:	Source: Link to the current ClinicalTrials.gov record., First posted: June 15, 2018, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024

Study ID:	NCT03558724 NL65856.042.18
Veröffentlichungen zur Studie:	Duan XF, Tang P, Yu ZT. Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review. Cancer Biol Med. 2014 Sep;11(3):191-201. doi: 10.7497/j.issn.2095-3941.2014.03.005. Booka E, Takeuchi H, Nishi T, Matsuda S, Kaburagi T, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Omori T, Kitagawa Y. The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer. Medicine (Baltimore). 2015 Aug;94(33):e1369. doi: 10.1097/MD.0000000000001369. Erratum In: Medicine (Baltimore). 2015 Sep;94(39):1. Raymond D. Complications of esophagectomy. Surg Clin North Am. 2012 Oct;92(5):1299-313. doi: 10.1016/j.suc.2012.07.007.

fisyears:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG00275472X


LEADER	01000caa a22002652 4500
001	CTG00275472X
003	DE-627
005	20240424010447.0
007	cr uuu---uuuuu
008	210408s2024 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)CTG00275472X
035			\|a (UBBS_Klinische_Studien)NCT03558724
035			\|a (UBBS_Klinische_Studien)NL65856.042.18
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Fluorescence Endoscopy of Esophageal Carcinoma \|b Fluorescence Molecular Endoscopy of Locally Advanced Esophageal Carcinoma Using Bevacizumab-800CW to Evaluate Dose Response After Neoadjuvant Chemoradiotherapy: a Single-center Feasibility Study.
264		1	\|c 2024
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Source: Link to the current ClinicalTrials.gov record., First posted: June 15, 2018, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024
520			\|a See brief summary
650		2	\|a Esophageal Neoplasms
650		4	\|a Study Type: Interventional
650		4	\|a Recruitment Status: Terminated
650		4	\|a Phase: Phase 1
650		4	\|a 610
773	0	8	\|i Enthalten in \|t ClinicalTrials.gov \|g (2024) vom: 16. Apr.
773	1	8	\|g year:2024 \|g day:16 \|g month:04
856	4	0	\|u https://clinicaltrials.gov/show/NCT03558724 \|x 0 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2024 \|b 16 \|c 04